XNAS
OPCH
Market cap4.65bUSD
Oct 08, Last price
31.05USD
1D
0.13%
1Q
43.95%
Jan 2017
646.39%
Name
Option Care Health Inc
Chart & performance
P/E
22.40
P/S
0.82
EPS
1.39
Div yield, %
—
Shrs. gr., 5y
-2.03%
Rev. gr., 5y
13.25%
Revenues
5.65b
+13.03%
Net income
208m
-2.00%
CFO
258m
-20.08%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Currently, BioPlus Acquisition Corp. possesses no major active business operations. Its express mandate is to pursue and complete a strategic combination, which may take the form of a merger, share exchange, asset purchase, stock acquisition, reorganization, or similar transaction. This targeted consolidation is specifically aimed at one or more entities within the vibrant life sciences industry. The corporation was formally established in 2021 and maintains its principal executive offices in New York, New York.
Related entities
Subsidiaries
OPTION CARE INFUSION SERVICES, INC.
Key people
Independent Chairman of the Board · since 2019
Harriet Booker
Chief Operating Officer, Senior Vice President · since 2017
Richard P. Denness
Senior Vice President, Chief Commercial Officer · since 2018
Kimberlee Seah
Senior Vice President, General Counsel, Secretary · since 2011
Timothy P. Sullivan
Director · since 2019
Mark Edmund Vainisi
Director · since 2019
John J. Arlotta
Independent Director · since 2019
Legal address
C/O THE CORPORATION TRUST COMPANY
CORPORATION TRUST CENTER 1209 ORANGE ST
WILMINGTON, DE 19801
US
CORPORATION TRUST CENTER 1209 ORANGE ST
WILMINGTON, DE 19801
US
Headquarters
3000 Lakeside Drive
Suite 300N
Bannockburn, IL 60015
US
Suite 300N
Bannockburn, IL 60015
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||